Director’s Innovation Speaker Series: Beyond FDA Approval: Assessing the Value of New Health Technologies

Foluso Agboola, MBBS, MPH provided a brief background on the Institute for Clinical and Economic Review (ICER) and describe the Value Assessment Framework using their review of esketamine for treatment-resistant depression as an example.

Add a Comment

Your email address will not be published. Required fields are marked *